Loading
Latest filing published 02 Jul 2024 for bioAffinity Technologies, Inc..
Not enough history yet: 0 closed purchases, at least 2 are needed.
Robert A. Anderson is a declared insider of bioAffinity Technologies, Inc., with filings sourced from SEC (Form 4). Between 31 August 2022 and 1 July 2024, the trades on record add up to 9 filings.
On the market, this insider has only ever bought: 1 purchase. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 7 share grants and 1 option exercise.
On 2 July 2024 came the latest disclosure, a share grant in bioAffinity Technologies, Inc. The clock since the last published purchase (2 December 2022) now reads 1,422 days. Filings reach the SEC (Form 4) feed a median of 32 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations